Nanomaterials represent a promising novel class of materials to be used as antibacterial solutions. Inhomogeneity of synthesis and characterization methods, as well as resulting variate physical and chemical properties make selection of proper nanostructure difficult when designing antimicrobial experiments. Present study focuses on the already existing evidence regarding silver nanoparticles and their antibacterial applications, with focus on various modulatory factors of reported antimicrobial efficiency. Present paper focuses on synthesis and characterization methods, factors modulating antibacterial efficiency, laboratory quantification procedures, as well as up–to-date knowledge on mechanisms of antibacterial action for silver nanoparticles. Moreover, challenges and future prospects for antimicrobial applications of silver nanoparticles are reviewed and discussed.
Metallic nanoparticles are a new class of materials with applications in medicine, pharmaceutical and agriculture. Using biological, chemical and physical approaches, nanoparticles with amazing properties are obtained. Copper is one of the most-found elements and plays an important part in the normal functioning of organisms. Coper nanoparticles have superior antibacterial properties when comparing them to present day antibiotics. Moreover, apart from their antibacterial role, antifungal, antiviral and anticancer properties have been described. Although the mechanism of actions is not completely understood, copper nanoparticles can become a viable alternative in fighting multi-resistant bacteria strains. We hereby review the already existing data on copper nanoparticle synthesis, effects and mechanisms of action as well as toxicity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.